Showing results (221-230 of 367) with videos related to

Sort By:
Pageof 37
Biochemical and Biophysical Research Communications|December 19, 2000
Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanismsN Sogo, K S Magid, C A Shaw, et al.
Circulation|October 31, 2001
Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failureF N Witherow, A Helmy, D J Webb, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 1997
Seasonal variation in glucocorticoid activity in healthy menB R Walker, R Best, J P Noon, et al.
Optics Letters|September 4, 2012
Arbitrary real-time three-dimensional corporal object sensing and reconstruction schemeR S Bhamber, T Allsop, G Lloyd, et al.
European Journal of Biochemistry|July 1, 1982
Effect of cyclic nucleotide analogs on intrachain site I of protein kinase isozymesJ D Corbin, S R Rannels, D A Flockhart, et al.
British Journal of Clinical Pharmacology|July 25, 2000
Constriction to ETB receptor agonists, BQ-3020 and sarafotoxin s6c, in human resistance and capacitance vessels in vivoF E Strachan, T R Crockett, N L Mills, et al.
Scottish Medical Journal|March 12, 2004
Physician opinions on the implementation of the SIGN guideline for heart failureS P McKee, S J Leslie, J P LeMaitre, et al.
Optics Letters|October 28, 2009
Simultaneous interrogation of interferometric and Bragg grating sensorsG Brady, K Kalli, D J Webb, et al.
Circulation|November 1, 1996
Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitorsM P Love, W G Haynes, G A Gray, et al.
Kidney International|September 1, 1995
Erythropoietin enhances vascular responsiveness to norepinephrine in renal failureM F Hand, W G Haynes, H A Johnstone, et al.
Pageof 37